| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205137 for enzyme resistance/gene overexpression; allow in vitro synthesis of homogenous N-glycans or glycoconjugates |
| 04/17/2007 | US7205134 Δ4-desaturase genes and uses thereof |
| 04/17/2007 | US7205119 HA-1 antigen |
| 04/17/2007 | US7205113 Regulation of T cell responses, T cell proliferation, and induction of T cell death |
| 04/17/2007 | US7205110 increasing chemokine production; useful for the treatment of inflammatory bowel disease and irritable bowel syndrome; detecting inflammatory bowel disease by screening for certain polypeptide or polynucleotide sequences |
| 04/17/2007 | US7205107 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays |
| 04/17/2007 | US7205103 Method of regulating transcription in a cell |
| 04/17/2007 | US7205101 Replicating DNA specific for HIV by growing a unicellular microorganism containing a DNA construct having an origin of replication recognized by the microorganism and sequence comprising at least a 20 bp sequence of a human immunodeficiency virus genome |
| 04/17/2007 | US7205002 For causing a cell to die, for reducing intracellular glutathione, and sensitizing a cell to cytotoxic agents that the cell is resistant to due to the presence of intracellular glutathione |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/17/2007 | US7204993 For the protection of fish against infection by the same and other virulent strains Streptococcus agalactiae |
| 04/17/2007 | US7204991 Porphyromonas gingivalis recombinant proteins and truncations |
| 04/17/2007 | US7204989 For diagnosis of Hepatitis E virus, use in a vaccine for the prevention of HEV in humans |
| 04/17/2007 | US7204985 Tumor necrosis factor (TNF); antibody inhibitors; immunotherapy; gene therapy |
| 04/17/2007 | US7204981 Methods of treating diseases with activated protein C |
| 04/17/2007 | US7204980 Methods for inhibiting viral replication in vivo |
| 04/17/2007 | US7204978 Treatment and diagnosis of infertility using TGFβ or activin |
| 04/17/2007 | US7204972 Annexin derivatives with endogenous chelation sites |
| 04/17/2007 | CA2395835C Method and system for providing a customized media list |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2337051C Methods for increasing vascularization and promoting wound healing |
| 04/17/2007 | CA2308721C Radio-opaque polymer biomaterials |
| 04/17/2007 | CA2283648C Polymeric carrier |
| 04/17/2007 | CA2211314C A process for preparing certain aza cyclohexapeptides |
| 04/17/2007 | CA2202477C Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 04/17/2007 | CA2196876C Trefoil peptide dimer |
| 04/17/2007 | CA2184175C Isolated, tyrosinase derived peptides and uses thereof |
| 04/17/2007 | CA2166292C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 04/17/2007 | CA2153789C Biologically active tgf-.beta.1 and tgf-.beta.2 peptides |
| 04/17/2007 | CA2141212C Defective adenovirus and corresponding complementation lines |
| 04/17/2007 | CA2133205C Stable polypeptide composition |
| 04/17/2007 | CA2123912C Muramyl compounds for treatment of septic shock |
| 04/17/2007 | CA2100690C Megakaryocyte differentiation factor |
| 04/17/2007 | CA1341525C Biologically active bactericidal/permeability-increasing protein fragments |
| 04/14/2007 | CA2564064A1 Genetic variations associated with psychiatric disorders |
| 04/14/2007 | CA2523399A1 Genetic variations associated with psychiatric disorders |
| 04/12/2007 | WO2007046971A2 Antiepileptogenic complex of albumin with docosahexaenoate |
| 04/12/2007 | WO2007041664A1 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 04/12/2007 | WO2007041631A1 ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION |
| 04/12/2007 | WO2007041614A2 Long acting vegf inhibitors and methods of use |
| 04/12/2007 | WO2007041610A2 Genes and proteins associated with angiogenesis and uses thereof |
| 04/12/2007 | WO2007041525A2 Method of treating pancreatitis |
| 04/12/2007 | WO2007041487A2 Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family |
| 04/12/2007 | WO2007041481A1 Rapid acting and prolonged acting insulin preparations |
| 04/12/2007 | WO2007041439A2 Centrosomal proteins, nucleic acids and method of use thereof |
| 04/12/2007 | WO2007041438A2 Compositions comprising glycerophosphodiester phosphodiesterase (gde) and uses thereof |
| 04/12/2007 | WO2007041435A1 Methods for treating pain and hyperhidrosis |
| 04/12/2007 | WO2007041317A2 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | WO2007041285A2 Complexes of inactivated pepsin fraction and heat shock protein |
| 04/12/2007 | WO2007041279A2 Methods to treat t-cell disorders using tisf |
| 04/12/2007 | WO2007041278A2 Composition and methods for stimulating gastrointestinal motility |
| 04/12/2007 | WO2007041240A2 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2 |
| 04/12/2007 | WO2007041206A2 Drug delivery nanocarriers targeted by landscape phage |
| 04/12/2007 | WO2007041190A2 Polymer-based delivery system for immunotherapy of cancer |
| 04/12/2007 | WO2007040711A2 Pharmaceutical formulations |
| 04/12/2007 | WO2007040591A2 A ubiquinone composition and a container for its convenient transport and storage |
| 04/12/2007 | WO2007040522A1 Antitumor agents |
| 04/12/2007 | WO2007040437A1 Fusion proteins having a modulated half-life in plasma |
| 04/12/2007 | WO2007040212A1 Neuronal differentiation inhibitor peptide and use thereof |
| 04/12/2007 | WO2007039911A1 Agent and compositions comprising the same for inhibiting lipases and/or phospholipases in body fluids, cells and tissues |
| 04/12/2007 | WO2007039788A1 Composition and methods for inhibiting h. pylori adhesion and infection |
| 04/12/2007 | WO2007039722A1 POLYMORPHISMS IN PONl ARE ASSOCIATED WITH ELEVATED ALANINE AMINOTRANSFERASE LEVELS AFTER XIMELAGATRAN OR TACRINE ADMINISTRATION |
| 04/12/2007 | WO2007039475A1 Human coagulation factor vii polypeptides |
| 04/12/2007 | WO2007039436A1 Treatment of neurodegenerative disorders |
| 04/12/2007 | WO2007039318A2 Neuropeptide y analogs |
| 04/12/2007 | WO2007039231A2 Method of producing a modified (poly)peptide |
| 04/12/2007 | WO2007039151A1 Blockers of transforming growth factor beta and its receptors for the treatment of infectious diseases |
| 04/12/2007 | WO2007039109A1 Tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi) -anchors for treatment of cancer and skin lesions |
| 04/12/2007 | WO2007038995A1 Factor h for the treatment of chronic nephropathies and production thereof |
| 04/12/2007 | WO2007038943A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | WO2007038942A1 Y4 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | WO2007038933A2 A method for producing cells with efficient engraftment within the heart |
| 04/12/2007 | WO2007038876A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | WO2007038874A1 Grape seed extract and its constituents for use as cyp2a6 inhibitors |
| 04/12/2007 | WO2007038870A1 A DAIRY DERIVED COMPOSITION ENRICHED IN TGF-β FOR TREATING INFLAMMATION |
| 04/12/2007 | WO2007022101A3 Treatment of diseases by subcutaneous administration of a vegf antagonist |
| 04/12/2007 | WO2007015170A8 Synapse-specific proteins in glomeruli |
| 04/12/2007 | WO2007006095A3 Chaperonin 10-induced immunomodulation |
| 04/12/2007 | WO2006138043A3 Method and compositions for the treatment of diabetes and related complications |
| 04/12/2007 | WO2006137974A3 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 04/12/2007 | WO2006136159A3 Lipases for pharmaceutical use |
| 04/12/2007 | WO2006131515A3 Stabilised il-21 compositions |
| 04/12/2007 | WO2006129867A3 ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN |
| 04/12/2007 | WO2006128455A3 Compounds modifying apoptosis |
| 04/12/2007 | WO2006128196A3 Novel substrate for rpn 11 enzymatic activity |
| 04/12/2007 | WO2006128026A3 Cellular receptor for varicella-zoster virus, methods of inhibiting spread of varicella-zoster and methods of increasing stability and infectivity of the virus |
| 04/12/2007 | WO2006127822A3 Scytovirin domain 1 related polypeptides |
| 04/12/2007 | WO2006125077A9 Non-natural chemokine receptor ligands and methods of use thereof |
| 04/12/2007 | WO2006123361A3 Microspheres containing goserelin or a pharmaceutically acceptable salt thereof |
| 04/12/2007 | WO2006121869A3 Compositions and methods for treating mood and anxiety disorders |
| 04/12/2007 | WO2006121860A3 Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use |
| 04/12/2007 | WO2006119912A3 Use of histones for therapeutic purposes |
| 04/12/2007 | WO2006113360A3 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi) |
| 04/12/2007 | WO2006111866A3 Hiv vif mutants |
| 04/12/2007 | WO2006110599A3 Cacna1e in cancer diagnosis, detection and treatment |
| 04/12/2007 | WO2006108417A3 Mannan-binding lectin (mbl) in the treatment of immunocompromised conditions associated with cancer |
| 04/12/2007 | WO2006105325A3 Compositions comprising wnt-3 peptide for modulating medial-lateral neuronal topographic maps |
| 04/12/2007 | WO2006102901A3 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 04/12/2007 | WO2006097110A3 Polypeptides having antimicrobial activity and polynucleotides encoding same |